ArticleInvestigational new drugs2019

A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study.

Manuel Ruiz-Borrego et al.PubMed ↗Publisher ↗

No numbers read from the abstract.